The potential therapeutic role of lymph node resection in epithelial ovarian cancer: A study of 13 918 patients

British Journal of Cancer

Volumn 96, Issue 12, 2007, Pages 1817-1822

  Chan, J K ^a   Urban, R ^b   Hu, J M ^b   Shin, J Y ^b   Husain, A ^b   Teng, N N ^b   Berek, J S ^b   Osann, K ^c   Kapp, D S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lymph node resection; Ovarian cancer; Survival

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; SCHOOL CHILD;

FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 34250349881     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603803     Document Type: Article

References (26)

1. Arango HA, Hoffman MS, Roberts WS, DeCesare SL, Fiorica JV, Drake J (2000) Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Obstet Gynecol 95: 553-556
2. Baiocchi G, Grosso G, di Re E, Fontanelli R, Raspagliesi F, di Re F (1998) Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer. Gynecol Oncol 69: 151-156
3. Benedetti Panici P, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, Tamussino K, Winter R, Pellegrino A, Greggi S, Angioli R, Manci N, Scambia G, Dell'Anna T, Fossati R, Floriani I, Rossi RS, Grassi R, Favalli G, Raspagliesi F, Giannarelli D, Martella L, Mangioni C (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97: 560-566
4. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20: 1248-1259
5. Burghardt E, Girardi F, Lahousen M, Tamussino K, Stettner H (1991) Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40: 103-106
6. Burghardt E, Lahousen M, Stettner H (1989) The significance of pelvic and para-aortic lymphadenectomy in the operative treatment of ovarian cancer. Baillieres Clin Obstet Gynaecol 3: 157-165
7. Burghardt E, Pickel H, Lahousen M, Stettner H (1986) Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 155: 315-319
8. Burghardt E, Winter R (1989) The effect of chemotherapy on lymph node metastases in ovarian cancer. Baillieres Clin Obstet Gynaecol 3: 167-171
9. Carnino F, Fuda G, Ciccone G, Iskra L, Guercio E, Dadone D, Conte PF (1997) Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 65: 467-472
10. Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K (2007) Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 109: 12-19
11. Chen SS, Lee L (1983) Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynecol Oncol 16: 95-100
12. Covens AL (2000) A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol 78: 269-274
13. Eisenkop SM, Spirtos NM (2001) The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Gynecol Oncol 82: 143-149
14. Hankey BF, Ries LA, Edwards BK (1999) The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 8: 1117-1121
15. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130
16. Kikkawa F, Ishikawa H, Tamakoshi K, Suganuma N, Mizuno K, Kawai M, Arii Y, Tamakoshi A, Kuzuya K, Tomoda Y (1995) Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J Surg Oncol 60: 227-231
17. Maggioni A, Benedetti Panici P, Dell'Anna T, Landoni F, Lissoni A, Pellegrino A, Rossi RS, Chiari S, Campagnutta E, Greggi S, Angioli R, Manci N, Calcagno M, Scambia G, Fossati R, Floriani I, Torri V, Grassi R, Mangioni C (2006) Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 95: 699-704
18. Marsden DE, Friedlander M, Hacker NF (2000) Current management of epithelial ovarian carcinoma: a review. Semin Surg Oncol 19: 11-19
19. Onda T, Yoshikawa H, Yokota H, Yasugi T, Taketani Y (1996) Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy. Cancer 78: 803-808
20. Petru E, Lahousen M, Tamussino K, Pickel H, Stranzl H, Stettner H, Winter R (1994) Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170: 656-662
21. Piver MS, Lele SB, Marchetti DL, Baker TR, Tsukada Y, Emrich LJ (1988) The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol 6: 983-989
22. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta E (1995) Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol 56: 328-337
23. Spirtos NM, Gross GM, Freddo JL, Ballon SC (1995) Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 56: 345-352
24. Surveillance, Epidemiology and End Results (SEER) program SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch http//:www.seer.cancer.gov
25. Tangjitgamol S, Manusirivithaya S, Sheanakul C, Leelahakorn S, Sripramote M, Thawaramara T, Kaewpila N (2003) Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma? Int J Gynecol Cancer 13: 297-302
26. Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S (2003) Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95: 113-125